Results
71,174 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 46 | Ziegler Christoph SamuelDirector |  VRXAVeraxa Biotech AG - Post de-SPACOpen-market purchase | BUY | $33K 30.0K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 46 | Ziegler Christoph SamuelDirector | VRXAVeraxa Biotech AG - Post de-SPAC Open-market purchase | BUY | $33K 30.0K sh |
| Oct 21, 2026 traded Oct 20, 2026 |
| 44 | Bradshaw JoshuaDirector, Vice Chairman and President |  CLMCornerstone Strategic Investment Fund, Inc.Open-market purchase | BUY | $97K 16.0K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 44 | Bradshaw JoshuaDirector, Vice Chairman and President |  CRFCORNERSTONE TOTAL RETURN FUND INCOpen-market purchase | BUY | $118K 20.0K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 39 | Kamfar RaminDirector |  BPREBluerock Private Real Estate FundOpen-market purchase | BUY | $1.14M 92.0K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 39 | Canton Barry10% Owner |  DNAGinkgo Bioworks Holdings, Inc.Open-market sale | SELL | $191K 18.8K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 39 | Shetty Reshma P.Director, See remarks, 10% Owner | DNAGinkgo Bioworks Holdings, Inc. Open-market sale | SELL | $191K 18.8K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 39 | Kamfar RaminDirector | BPREBluerock Private Real Estate Fund Open-market purchase | BUY | $1.41M 114.9K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 36 | Kamfar RaminDirector | BPREBluerock Private Real Estate Fund Open-market purchase | BUY | $793K 64.7K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 35 | Shetty Reshma P.Director, See remarks, 10% Owner | DNAGinkgo Bioworks Holdings, Inc. Open-market sale | SELL | $227K 22.4K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 35 | Canton Barry10% Owner | DNAGinkgo Bioworks Holdings, Inc. Open-market sale | SELL | $227K 22.4K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 32 | ADAR1 Capital Management, LLC10% Owner |  TENXTENAX THERAPEUTICS, INC.Open-market purchase | BUY | $507K 336.5K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 32 |  Slootman FrankDirector |  SNOWSnowflake Inc.Open-market sale · 10b5-1 plan | SELL | $26.16M 82.4K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 32 | Coen Steven P.See remarks | DNAGinkgo Bioworks Holdings, Inc. Open-market sale | SELL | $7,770 766 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 31 | Hicks Mack H.Director, 10% Owner |  BENFBeneficientGrant or award | A | — 20.9K sh | Oct 21, 2026 traded Sep 30, 2026 |
| 31 | Magnani Alexandre MrDirector |  PAGSPagSeguro Digital Ltd.Open-market sale | SELL | $528K 47.1K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 30 | Berntsen RobertExecutive Vice President |  AEPAMERICAN ELECTRIC POWER CO INCGrant or award | A | $2.50M 20.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 30 | Cannon Douglas APresident AEP Transmission | AEPAMERICAN ELECTRIC POWER CO INC Grant or award | A | $2.50M 20.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 30 | Qiming Corporate GP VI, Ltd.10% Owner |  ALMRAlamar Biosciences, Inc.Open-market sale | SELL | $1.29M 49.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 28 | ADAR1 Capital Management, LLC10% Owner | TENXTENAX THERAPEUTICS, INC. Open-market purchase | BUY | $551K 332.0K sh | Oct 21, 2026 traded Oct 21, 2026 |
| 28 | Wang Chun KaiDirector, Chief Executive Officer |  OWLSOBOOK HOLDINGS INC.Open-market purchase | BUY | $52K 12.2K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 28 | Lht I, Llc10% Owner |  DAICCID Holdco, Inc.Open-market sale | SELL | $130K 120.0K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 28 | Saba Capital Management, L.P.10% Owner |  DSMBNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC.Open-market purchase | BUY | $78K 14.6K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 28 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $192K 4,003 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 28 | ADAR1 Capital Management, LLC10% Owner | TENXTENAX THERAPEUTICS, INC. Open-market purchase | BUY | $406K 254.3K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 28 | Slootman FrankDirector | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $21.63M 68.4K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 28 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 4,003 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 28 | Slootman FrankDirector | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $12.51M 39.3K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 28 | Saba Capital Management, L.P.10% Owner |  GFNEW GERMANY FUND INCOpen-market purchase | BUY | $907K 87.6K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 27 | Qiming Corporate GP VI, Ltd.10% Owner | ALMRAlamar Biosciences, Inc. Open-market sale | SELL | $301K 11.4K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 27 | Wendel KarenDirector | BENFBeneficient Grant or award | A | — 25.7K sh | Oct 21, 2026 traded Sep 30, 2026 |
| 27 | Qiming Corporate GP VI, Ltd.10% Owner | ALMRAlamar Biosciences, Inc. Open-market sale | SELL | $361K 13.7K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 27 | Kelly Jason RDirector, See remarks | DNAGinkgo Bioworks Holdings, Inc. Option exercise | M | — 55.7K sh | Oct 21, 2026 traded Oct 16, 2026 |
| 27 | Kiessling HeatherChief Financial Officer |  ASPIASP Isotopes Inc.Open-market sale | SELL | $48K 21.8K sh | Oct 21, 2026 traded Oct 16, 2026 |
| 26 | Nicholas J. CalamariDirector |  BETRBetter Home & Finance Holding CoOpen-market sale | SELL | $14K 1,320 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 26 | Qiming Corporate GP VI, Ltd.10% Owner | ALMRAlamar Biosciences, Inc. Open-market sale | SELL | $2.02M 72.4K sh | Oct 21, 2026 traded Oct 20, 2026 |
| 25 | Saba Capital Management, L.P.10% Owner |  LEOBNY MELLON STRATEGIC MUNICIPALS, INC.Open-market purchase | BUY | $44K 7,724 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 25 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $8,188 169 sh | Oct 21, 2026 traded Oct 20, 2026 |
| 25 | Slootman FrankDirector | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $4.63M 14.5K sh | Oct 21, 2026 traded Oct 19, 2026 |
| 25 | Mcdearman JohnDirector, PRESIDENT AND CEO | NONEWILSON BANK HOLDING CO Open-market purchase | BUY | $1,700 20 sh | Oct 21, 2026 traded Oct 21, 2026 |
| 25 | Opaleye Management Inc.10% Owner |  GRCEGrace Therapeutics, Inc.Open-market purchase | BUY | $8,001 4,256 sh | Oct 21, 2026 traded Oct 19, 2026 |